Literature DB >> 26728392

[Management of periprosthetic infections of the knee].

N Renz1, C Perka1, A Trampuz2.   

Abstract

Endoprosthetic replacement is one of the most successful operations in current medicine. As the implantation of knee prostheses increases, the number of periprosthetic infections is also rising. In case of painful or early loosening of the prosthesis an infection should be excluded by joint aspiration. Retention of the prosthesis with change of mobile parts is possible only in acute infections (< 4 weeks after surgery or duration of symptoms of <3 weeks in the case of hematogenous infection), if the prosthesis is stable, the soft tissue is intact, and no difficult-to-treat pathogens were found. In other cases a one- or two-stage prosthesis exchange should be performed. In a two-stage exchange, a short interval of 2-3 weeks is possible, if biofilm-active treatment is available. Rifampin should be used targeted (after isolation of the pathogen) and only in combination with another efficient antibiotic. In this article the current management concepts of periprosthetic infection of the knee are discussed.

Entities:  

Keywords:  Antibiotic treatment; Biofilm; Management; Periprosthetic joint infection

Mesh:

Substances:

Year:  2016        PMID: 26728392     DOI: 10.1007/s00132-015-3217-6

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  24 in total

Review 1.  Challenges in periprosthetic knee-joint infection.

Authors:  Parham Sendi; Werner Zimmerli
Journal:  Int J Artif Organs       Date:  2011-09       Impact factor: 1.595

Review 2.  [Septic endoprosthesis exchange : Preoperative diagnosis and reimplantation].

Authors:  H M L Mühlhofer; J Schauwecker; I J Banke; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2015-12       Impact factor: 1.087

3.  Future clinical and economic impact of revision total hip and knee arthroplasty.

Authors:  Steven M Kurtz; Kevin L Ong; Jordana Schmier; Fionna Mowat; Khaled Saleh; Eva Dybvik; Johan Kärrholm; Göran Garellick; Leif I Havelin; Ove Furnes; Henrik Malchau; Edmund Lau
Journal:  J Bone Joint Surg Am       Date:  2007-10       Impact factor: 5.284

Review 4.  [Prosthetic joint infection: new developments in diagnosis and treatment].

Authors:  A Trampuz; C Perka; O Borens
Journal:  Dtsch Med Wochenschr       Date:  2013-07-24       Impact factor: 0.628

Review 5.  Revised histopathological consensus classification of joint implant related pathology.

Authors:  V Krenn; L Morawietz; G Perino; H Kienapfel; R Ascherl; G J Hassenpflug; M Thomsen; P Thomas; M Huber; D Kendoff; D Baumhoer; M G Krukemeyer; S Natu; F Boettner; J Zustin; B Kölbel; W Rüther; J P Kretzer; A Tiemann; A Trampuz; L Frommelt; R Tichilow; S Söder; S Müller; J Parvizi; U Illgner; T Gehrke
Journal:  Pathol Res Pract       Date:  2014-10-17       Impact factor: 3.250

Review 6.  Epidemiology and new developments in the diagnosis of prosthetic joint infection.

Authors:  Stéphane Corvec; María E Portillo; Bruna Maria Pasticci; Olivier Borens; Andrej Trampuz
Journal:  Int J Artif Organs       Date:  2012-10       Impact factor: 1.595

7.  Advantages of sonication fluid culture for the diagnosis of prosthetic joint infection.

Authors:  María Eugenia Portillo; Margarita Salvadó; Albert Alier; Santos Martínez; Lluisa Sorli; Juan P Horcajada; Lluis Puig
Journal:  J Infect       Date:  2014-03-12       Impact factor: 6.072

Review 8.  New strategies for the treatment of infections associated with prosthetic joints.

Authors:  Andrej Trampuz; Werner Zimmerli
Journal:  Curr Opin Investig Drugs       Date:  2005-02

9.  Multiplex PCR of sonication fluid accurately differentiates between prosthetic joint infection and aseptic failure.

Authors:  María Eugenia Portillo; Margarita Salvadó; Lluisa Sorli; Albert Alier; Santos Martínez; Andrej Trampuz; Julià Gómez; Lluis Puig; Juan Pablo Horcajada
Journal:  J Infect       Date:  2012-09-04       Impact factor: 6.072

10.  Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis.

Authors:  Andrej Trampuz; Werner Zimmerli
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

View more
  19 in total

Review 1.  [Implant-associated infections - Diagnostics].

Authors:  N Renz; M Müller; C Perka; A Trampuz
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

Review 2.  [Osteosynthesis-associated infections : Epidemiology, definition and diagnosis].

Authors:  N Renz; S Feihl; C E Dlaska; M A Schütz; A Trampuz
Journal:  Unfallchirurg       Date:  2017-06       Impact factor: 1.000

Review 3.  [Periprosthetic infections in patients with rheumatism : A challenge].

Authors:  J Fussi; C Perka; L Renner
Journal:  Z Rheumatol       Date:  2016-12       Impact factor: 1.372

Review 4.  [Treatment of periprosthetic infections].

Authors:  L Renner; C Perka; A Trampuz; N Renz
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

Review 5.  [Revision surgery in acute periprosthetic knee joint infections].

Authors:  T Hawellek; F T Beil; J Hubert
Journal:  Oper Orthop Traumatol       Date:  2018-07-27       Impact factor: 1.154

6.  [Infected endoprosthesis in patients with rheumatism].

Authors:  Markus Weber; M Meyer; J Grifka
Journal:  Z Rheumatol       Date:  2021-04-22       Impact factor: 1.372

Review 7.  [The significance of biofilm for the treatment of infections in orthopedic surgery : 2017 Update].

Authors:  C Scheuermann-Poley; C Wagner; J Hoffmann; A Moter; C Willy
Journal:  Unfallchirurg       Date:  2017-06       Impact factor: 1.000

Review 8.  [Antibiotic strategies in trauma surgery : Treatment of implant-associated infections].

Authors:  Susanne Feihl; Nora Renz; Michael Schütz; Michael Müller
Journal:  Unfallchirurg       Date:  2017-06       Impact factor: 1.000

Review 9.  [Local antibiotic therapy].

Authors:  Klaus-Dieter Kühn; Nora Renz; Andrej Trampuz
Journal:  Unfallchirurg       Date:  2017-07       Impact factor: 1.000

Review 10.  Periprosthetic Joint Infection of Shoulder Arthroplasties: Diagnostic and Treatment Options.

Authors:  Bernd Fink; Florian Sevelda
Journal:  Biomed Res Int       Date:  2017-12-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.